Full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration

被引：0

作者：

Lee, Sang Hyeok ^{[1
]}

Lee, Mee Yon ^{[1
]}

机构：

[1] Catholic Univ Korea, Coll Med, Dept Ophthalmol, Seoul, South Korea

来源：

EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2025年 / 35卷 / 01期

关键词：

Macular hole; anti-VEGF; brolucizumab; RETINAL-PIGMENT EPITHELIUM; RANIBIZUMAB; DETACHMENT;

D O I：

10.1177/11206721241286708

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Purpose To describe a case of full thickness macular hole after intravitreal brolucizumab injection in neovascular age-related macular degeneration, which has not been reported to date.Case description A 65-year-old male patient received brolucizumab intravitreal injection therapy for neovascular macular degeneration of the right eye. He received multiple intravitreal anti-VEGF injections on a pro re nata regimen and developed a full thickness macular hole.Outcome Surgical treatment was performed with pars plana vitrectomy of the right eye. Full thickness macular hole was successfully treated.Conclusion Although a full thickness macular hole following intravitreal brolucizumab injection is an uncommon complication, it requires caution.

引用

页码：NP16 / NP19

页数：4

共 10 条

[1] Macular Hole Formation in the Presence of a Pigment Epithelial Detachment After Three Consecutive Intravitreal Antivascular Endothelial Growth Factor Injections [J].

Clemens, Christoph R. ;

Holz, Frank G. ;

Meyer, Carsten H. .

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (03) :297-299

[2] Full-thickness macular hole after intravitreal injection of ranibizumab in a patient with retinal pigment epithelium detachment and tear [J].

Grigoropoulos, Vlassis ;

Emfietzoglou, John ;

Nikolaidis, Pantelis ;

Theodossiadis, George ;

Theodossiadis, Panagiotis .

EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2010, 20 (02) :469-472

[3] Common eye diseases of elderly people: Identifying and treating causes of vision loss [J].

Harvey, PT .

GERONTOLOGY, 2003, 49 (01) :1-11

[4]

Joon Jo Young, 2010, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V51, P774

[5]

Karamitsos A., 2021, CUREUS J MED SCIENCE, V13

[6] Side Effects of Brolucizumab [J].

Motevasseli, Tahmineh ;

Mohammadi, Saeed ;

Abdi, Fatemeh ;

Freeman, William R. .

JOURNAL OF OPHTHALMIC & VISION RESEARCH, 2021, 16 (04) :670-675

[7] Tearing of the Retinal Pigment Epithelium after Intravitreal Injection of Brolucizumab [J].

Park, Joon Young ;

Moon, Jong Won .

JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2022, 63 (08) :721-726

[8] Macular hole following intravitreal ranibizumab injection for choroidal neovascular membrane caused by age-related macular degeneration [J].

Querques, Giuseppe ;

Souied, Eric H. ;

Soubrane, Gisele .

ACTA OPHTHALMOLOGICA, 2009, 87 (02) :235-237

[9] Macular Hole Formation Following Intravitreal Aflibercept for Neovascular Age-Related Macular Degeneration [J].

Said, Yasmin Ali ;

Vanwynsberghe, David ;

Jacob, Julie .

CASE REPORTS IN OPHTHALMOLOGY, 2022, 13 (01) :247-252

[10] Brolucizumab: A Newly Developed Anti-VEGF Molecule for the Treatment of Neovascular Age-Related Macular Degeneration [J].

Tadayoni, Ramin ;

Sararols, Laura ;

Weissgerber, Georges ;

Verma, Rohini ;

Clemens, Andreas ;

Holz, Frank G. .

OPHTHALMOLOGICA, 2021, 244 (02) :93-101

← 1 →